$1.65
00.00%
Pre-Market: 5:39 AM EDT
Metagenomi reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Metagenomi using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-13 | $-0.45 | $-0.78 | 42.3 % |
Jun 2024 | 2024-08-14 | $-0.29 | $-0.65 | 55.4 % |
Mar 2024 | 2024-05-14 | $-1.19 | $-0.80 | -48.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-13 | $11.51M | $6.79M | 69.6 % |
Jun 2024 | 2024-08-14 | $20.01M | $13.98M | 43.1 % |
Mar 2024 | 2024-05-14 | $11.16M | $7.37M | 51.4 % |
Metagenomi (MGX) is scheduled to report earnings on February 12, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.45, which beat the estimate of $-0.78.
The Actual Revenue was $11.5M, which beat the estimate of $6.8M.
Browse earnings estimates, EPS, and revenue on all stocks.